Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Executive Vice President | February 26, 2007 | February 28, 2007 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date February 26, 2007 · Filed February 28, 2007
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares without par valueSEC Table I · non-derivative | Direct | 120,427 |
Ending reported balance
After 2007-02-26 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2007-02-26 · Exercise / conversion · Acquired 1,954 · Balance 118,553 Row 2 · 2007-02-26 · Exercise / conversion · Acquired 1,393 · Balance 119,946 Row 3 · 2007-02-26 · Exercise / conversion · Acquired 14,515 · Balance 134,461 Row 4 · 2007-02-26 · Tax withholding · Disposed 14,034 · Balance 120,427 |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $34.77 · Expires 2008-02-12 | Direct | 0 |
Reported balance
After 2007-02-26 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2007-02-26 · Exercise / conversion · Disposed 1,954 · Balance 0 F4: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.23 · Expires 2013-02-13 | Direct | 0 |
Reported balance
After 2007-02-26 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2007-02-26 · Exercise / conversion · Disposed 1,393 · Balance 0 F4: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.40 · Expires 2012-06-27 | Direct | 6,234 |
Reported balance
After 2007-02-26 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2007-02-26 · Exercise / conversion · Disposed 14,515 · Balance 6,234 F4: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $53.59 · Expires 2008-02-12 | Direct | 1,267 |
Reported balance
After 2007-02-26 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2007-02-26 · Grant · Acquired 1,267 · Balance 1,267 F4: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $53.59 · Expires 2013-02-13 | Direct | 1,072 |
Reported balance
After 2007-02-26 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2007-02-26 · Grant · Acquired 1,072 · Balance 1,072 F4: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $53.59 · Expires 2012-06-27 | Direct | 11,695 |
Reported balance
After 2007-02-26 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2007-02-26 · Grant · Acquired 11,695 · Balance 11,695 F4: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. |
| Common Shares without par valueSEC Table I · non-derivative | IndirectProfit Sharing Trust | 11,178 |
Reported balance
Holding disclosure · report date 2007-02-26 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 11,178 F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 27, 2007. |
| Common Shares without par valueSEC Table I · non-derivative | IndirectBy self for son | 357 |
Reported balance
Holding disclosure · report date 2007-02-26 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 357 F2: Reporting person disclaims beneficial ownership of all securities held by his sons. F3: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan in transactions exempt from Section 16 under Rule 16(a)-11. |
| Common Shares without par valueSEC Table I · non-derivative | IndirectBy self for son | 300 |
Reported balance
Holding disclosure · report date 2007-02-26 · row 7
Holding and transaction disclosures are not merged.
1 source rowRow 7 · Balance 300 F2: Reporting person disclaims beneficial ownership of all securities held by his sons. F3: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan in transactions exempt from Section 16 under Rule 16(a)-11. |
| Common Shares without par valueSEC Table I · non-derivative | IndirectBy self for son | 293 |
Reported balance
Holding disclosure · report date 2007-02-26 · row 8
Holding and transaction disclosures are not merged.
1 source rowRow 8 · Balance 293 F2: Reporting person disclaims beneficial ownership of all securities held by his sons. F3: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan in transactions exempt from Section 16 under Rule 16(a)-11. |
Filing footnotes · ownership attribution and instrument terms
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 27, 2007.
F2: Reporting person disclaims beneficial ownership of all securities held by his sons.
F3: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan in transactions exempt from Section 16 under Rule 16(a)-11.
F4: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 26, 2007 Filed Feb 28, 2007 22:16 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 11,695 | $0.00 Strike: $53.59 | $0.00 |
DisclosureSEC source: 0001104659-07-015035 · a4.xml · derivative · entry 14 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,695 Underlying: common shares · 11,695 shares Expires 2012-06-27 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 26, 2007 Filed Feb 28, 2007 22:16 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 1,072 | $0.00 Strike: $53.59 | $0.00 |
DisclosureSEC source: 0001104659-07-015035 · a4.xml · derivative · entry 13 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,072 Underlying: common shares · 1,072 shares Expires 2013-02-13 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 26, 2007 Filed Feb 28, 2007 22:16 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 1,267 | $0.00 Strike: $53.59 | $0.00 |
DisclosureSEC source: 0001104659-07-015035 · a4.xml · derivative · entry 12 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,267 Underlying: common shares · 1,267 shares Expires 2008-02-12 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 26, 2007 Filed Feb 28, 2007 22:16 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 14,515 | $0.00 Strike: $36.40 | $0.00 |
DisclosureSEC source: 0001104659-07-015035 · a4.xml · derivative · entry 11 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,234 Underlying: common shares · 14,515 shares Expires 2012-06-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 26, 2007 Filed Feb 28, 2007 22:16 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 1,393 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-07-015035 · a4.xml · derivative · entry 10 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 1,393 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 26, 2007 Filed Feb 28, 2007 22:16 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 1,954 | $0.00 Strike: $34.77 | $0.00 |
DisclosureSEC source: 0001104659-07-015035 · a4.xml · derivative · entry 9 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 1,954 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 26, 2007 Filed Feb 28, 2007 22:16 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon Shares without par value | 14,034 | $53.59 | $752,082.06 |
DisclosureSEC source: 0001104659-07-015035 · a4.xml · nonDerivative · entry 4 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,427 Read SEC document |
| February 26, 2007 Filed Feb 28, 2007 22:16 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon Shares without par value | 14,515 | $36.40 | $528,324.23 |
DisclosureSEC source: 0001104659-07-015035 · a4.xml · nonDerivative · entry 3 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,461 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2007 Filed Feb 28, 2007 22:16 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon Shares without par value | 1,393 | $33.23 | $46,291.34 |
DisclosureSEC source: 0001104659-07-015035 · a4.xml · nonDerivative · entry 2 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,946 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2007 Filed Feb 28, 2007 22:16 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon Shares without par value | 1,954 | $34.77 | $67,945.86 |
DisclosureSEC source: 0001104659-07-015035 · a4.xml · nonDerivative · entry 1 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,553 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2007 Filed Feb 20, 2007 23:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 3,156 | $52.49 | $165,658.44 |
DisclosureSEC source: 0001104659-07-012373 · a4.xml · nonDerivative · entry 7 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,599 Read SEC document |
| February 18, 2007 Filed Feb 20, 2007 23:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 1,222 | $52.49 | $64,142.78 |
DisclosureSEC source: 0001104659-07-012373 · a4.xml · nonDerivative · entry 6 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,755 Read SEC document |
| February 17, 2007 Filed Feb 20, 2007 23:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 3,486 | $52.49 | $182,980.14 |
DisclosureSEC source: 0001104659-07-012373 · a4.xml · nonDerivative · entry 5 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,977 Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 23:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 112,000 | $0.00 Strike: $52.54 | $0.00 |
DisclosureSEC source: 0001104659-07-012373 · a4.xml · derivative · entry 12 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,000 Underlying: common shares · 112,000 shares Expires 2017-02-15 F6 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 37,334 on 2/16/2008, 37,333 on 2/16/09, and 37,333 on 2/16/10. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 23:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 21,000 | $52.54 | $1,103,340.00 |
DisclosureSEC source: 0001104659-07-012373 · a4.xml · nonDerivative · entry 3 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,632 F2 · kind: These shares represent a retention award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2007 Filed Feb 20, 2007 23:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 27,600 | $52.54 | $1,450,104.00 |
DisclosureSEC source: 0001104659-07-012373 · a4.xml · nonDerivative · entry 2 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,632 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 15, 2007 Filed Feb 20, 2007 23:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 5,169 | $52.70 | $272,406.30 |
DisclosureSEC source: 0001104659-07-012373 · a4.xml · nonDerivative · entry 4 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,463 Read SEC document |
| February 15, 2007 Filed Feb 20, 2007 23:24 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,500 | $52.81 | $79,215.00 |
DisclosureSEC source: 0001104659-07-012373 · a4.xml · nonDerivative · entry 1 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,032 Read SEC document |
| February 02, 2007 Filed Feb 5, 2007 23:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 2,678 | $0.00 Strike: $43.00 | $0.00 |
DisclosureSEC source: 0001104659-07-007300 · a4.xml · derivative · entry 10 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 2,678 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 02, 2007 Filed Feb 5, 2007 23:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 3,170 | $0.00 Strike: $51.29 | $0.00 |
DisclosureSEC source: 0001104659-07-007300 · a4.xml · derivative · entry 9 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 3,170 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 02, 2007 Filed Feb 5, 2007 23:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon Shares without par value | 5,848 | $52.61 | $307,651.58 |
DisclosureSEC source: 0001104659-07-007300 · a4.xml · nonDerivative · entry 4 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,532 Read SEC document |
| February 02, 2007 Filed Feb 5, 2007 23:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon Shares without par value | 2,678 | $43.00 | $115,154.00 |
DisclosureSEC source: 0001104659-07-007300 · a4.xml · nonDerivative · entry 3 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,380 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2007 Filed Feb 5, 2007 23:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon Shares without par value | 3,170 | $51.29 | $162,602.93 |
DisclosureSEC source: 0001104659-07-007300 · a4.xml · nonDerivative · entry 2 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 19, 2006 Filed Feb 5, 2007 23:13 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon Shares without par value | 1,424 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-07-007300 · a4.xml · nonDerivative · entry 1 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,532 Read SEC document |
| December 03, 2006 Filed Dec 5, 2006 21:58 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 3,156 | $46.60 | $147,069.60 |
DisclosureSEC source: 0001104659-06-079537 · a4.xml · nonDerivative · entry 1 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,956 Read SEC document |
| August 24, 2006 Filed Aug 28, 2006 21:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 825 | $0.00 Strike: $49.00 | $0.00 |
DisclosureSEC source: 0001104659-06-057619 · a4.xml · derivative · entry 14 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 825 Underlying: common shares · 825 shares Expires 2008-02-12 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 24, 2006 Filed Aug 28, 2006 21:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 7,726 | $0.00 Strike: $49.00 | $0.00 |
DisclosureSEC source: 0001104659-06-057619 · a4.xml · derivative · entry 13 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,726 Underlying: common shares · 7,726 shares Expires 2013-02-13 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 24, 2006 Filed Aug 28, 2006 21:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 2,039 | $0.00 Strike: $49.00 | $0.00 |
DisclosureSEC source: 0001104659-06-057619 · a4.xml · derivative · entry 12 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,039 Underlying: common shares · 2,039 shares Expires 2010-02-10 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 24, 2006 Filed Aug 28, 2006 21:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 1,163 | $0.00 Strike: $34.77 | $0.00 |
DisclosureSEC source: 0001104659-06-057619 · a4.xml · derivative · entry 11 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,954 Underlying: common shares · 1,163 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 24, 2006 Filed Aug 28, 2006 21:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 10,077 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-06-057619 · a4.xml · derivative · entry 10 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,393 Underlying: common shares · 10,077 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 24, 2006 Filed Aug 28, 2006 21:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 3,065 | $0.00 Strike: $32.61 | $0.00 |
DisclosureSEC source: 0001104659-06-057619 · a4.xml · derivative · entry 9 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 3,065 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 24, 2006 Filed Aug 28, 2006 21:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 10,590 | $49.00 | $518,910.00 |
DisclosureSEC source: 0001104659-06-057619 · a4.xml · nonDerivative · entry 4 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,112 Read SEC document |
| August 24, 2006 Filed Aug 28, 2006 21:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 1,163 | $34.77 | $40,440.65 |
DisclosureSEC source: 0001104659-06-057619 · a4.xml · nonDerivative · entry 3 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 24, 2006 Filed Aug 28, 2006 21:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 10,077 | $33.23 | $334,872.82 |
DisclosureSEC source: 0001104659-06-057619 · a4.xml · nonDerivative · entry 2 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,539 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 24, 2006 Filed Aug 28, 2006 21:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 3,065 | $32.61 | $99,953.02 |
DisclosureSEC source: 0001104659-06-057619 · a4.xml · nonDerivative · entry 1 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,462 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2006 Filed Aug 3, 2006 22:25 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 10,000 | $47.00 | $470,000.00 |
DisclosureSEC source: 0001104659-06-051249 · a4.xml · nonDerivative · entry 1 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,397 Read SEC document |
| February 18, 2006 Filed Feb 22, 2006 22:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 913 | $44.15 | $40,308.95 |
DisclosureSEC source: 0001104659-06-011227 · a4.xml · nonDerivative · entry 1 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,897 Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 83,000 | $0.00 Strike: $44.16 | $0.00 |
DisclosureSEC source: 0001104659-06-011227 · a4.xml · derivative · entry 7 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,000 Underlying: common shares · 83,000 shares Expires 2016-02-16 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) Rule 16b-3. The option becomes exercisable in annual increments of 27,667 on 2/17/2007, 27,667 on 2/17/2008 and 27,666 on 2/17/2009. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 26,500 | $44.16 | $1,170,240.00 |
DisclosureSEC source: 0001104659-06-011227 · a4.xml · nonDerivative · entry 2 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,397 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 00:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 11,754 | $0.00 Strike: $43.73 | $0.00 |
DisclosureSEC source: 0001104659-06-010255 · a4.xml · derivative · entry 9 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,754 Underlying: common shares · 11,754 shares Expires 2013-02-13 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 00:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 14,113 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-06-010255 · a4.xml · derivative · entry 8 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,470 Underlying: common shares · 14,113 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 00:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 339 | $44.07 | $14,939.73 |
DisclosureSEC source: 0001104659-06-010255 · a4.xml · nonDerivative · entry 3 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,810 Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 00:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 11,754 | $43.73 | $514,002.42 |
DisclosureSEC source: 0001104659-06-010255 · a4.xml · nonDerivative · entry 2 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,149 Read SEC document |
| February 15, 2006 Filed Feb 17, 2006 00:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 14,113 | $33.23 | $468,994.75 |
DisclosureSEC source: 0001104659-06-010255 · a4.xml · nonDerivative · entry 1 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,903 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 23:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 2,678 | $0.00 Strike: $43.00 | $0.00 |
DisclosureSEC source: 0001104659-06-005420 · a4.xml · derivative · entry 11 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,678 Underlying: common shares · 2,678 shares Expires 2007-02-13 F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 23:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 4,198 | $0.00 Strike: $27.43 | $0.00 |
DisclosureSEC source: 0001104659-06-005420 · a4.xml · derivative · entry 10 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 4,198 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 23:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 568 | $0.00 Strike: $20.53 | $0.00 |
DisclosureSEC source: 0001104659-06-005420 · a4.xml · derivative · entry 9 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 568 shares Expires 2006-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 23:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 2,949 | $43.00 | $126,807.00 |
DisclosureSEC source: 0001104659-06-005420 · a4.xml · nonDerivative · entry 4 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,790 Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 23:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 4,198 | $27.43 | $115,162.89 |
DisclosureSEC source: 0001104659-06-005420 · a4.xml · nonDerivative · entry 3 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,739 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 23:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 568 | $20.53 | $11,663.71 |
DisclosureSEC source: 0001104659-06-005420 · a4.xml · nonDerivative · entry 2 NEMMERS JOSEPH M · CIK 0001264007 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,541 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.